Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Given

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Journal of Endourology|May 22, 2009
Single center experience with percutaneous and laparoscopic cryoablation of small renal massesJohn B Malcolm, Tristan T Berry, Michael B Williams, et al.
The Journal of Urology|March 23, 2010
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancerJohn B Malcolm, Michael D Fabrizio, Bethany B Barone, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2006
What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?Patrick O Monahan, Victoria Champion, Susan Rawl, et al.
Cancer Nursing|October 5, 2021
The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation StudyFlorien W Boele, Jason Weimer, Amir H Zamanipoor Najafabadi, et al.
Medical Care|August 15, 2001
Screening for high utilizing somatizing patients using a prediction rule derived from the management information system of an HMO: a preliminary studyR C Smith, J C Gardiner, S Armatti, et al.
JCO Oncology Practice|April 2, 2024
Thresholds in PROMIS Scores Anchored to Subsequent Unscheduled Health Service Use Among People Diagnosed With CancerAlla Sikorskii, Samantha Tam, Barbara Given, et al.
Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.
Journal of Neuro-Oncology|February 25, 2016
Neuro-oncology family caregivers are at risk for systemic inflammationPaula R Sherwood, Thomas J Price, Jason Weimer, et al.
Journal of Endourology|April 25, 2017
Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland CryoablationYaw A Nyame, Ahmed Elshafei, Daniel J Greene, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN studyAxel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Journal of Endourology|May 22, 2009
Single center experience with percutaneous and laparoscopic cryoablation of small renal massesJohn B Malcolm, Tristan T Berry, Michael B Williams, et al.
The Journal of Urology|March 23, 2010
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancerJohn B Malcolm, Michael D Fabrizio, Bethany B Barone, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2006
What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?Patrick O Monahan, Victoria Champion, Susan Rawl, et al.
Cancer Nursing|October 5, 2021
The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation StudyFlorien W Boele, Jason Weimer, Amir H Zamanipoor Najafabadi, et al.
Medical Care|August 15, 2001
Screening for high utilizing somatizing patients using a prediction rule derived from the management information system of an HMO: a preliminary studyR C Smith, J C Gardiner, S Armatti, et al.
JCO Oncology Practice|April 2, 2024
Thresholds in PROMIS Scores Anchored to Subsequent Unscheduled Health Service Use Among People Diagnosed With CancerAlla Sikorskii, Samantha Tam, Barbara Given, et al.
Urology|November 16, 2005
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastasesThomas J Polascik, Robert W Given, Charles Metzger, et al.
Journal of Neuro-Oncology|February 25, 2016
Neuro-oncology family caregivers are at risk for systemic inflammationPaula R Sherwood, Thomas J Price, Jason Weimer, et al.
Journal of Endourology|April 25, 2017
Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland CryoablationYaw A Nyame, Ahmed Elshafei, Daniel J Greene, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN studyAxel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
Pageof 25